ALDX FY 2025 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ALDXAldeyra Therapeutics, Inc.

$318M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$251,993

Operating Income

-$35M

Net Income

-$34M

EPS (Diluted)

$-0.56

Cash Flow

Operating Cash Flow

-$33.3T

Free Cash Flow

-$33.3T

Stock-Based Comp.

$6.1T

Balance Sheet

Total Assets

$72.1T

Total Liabilities

$27.8T

Stockholders' Equity

$44.3T

Cash & Equivalents

$70.0T

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$251,993	$0	—
Operating Income	-$35M	-$60M	+41.3%
Net Income	-$34M	-$56M	+39.4%